✦ LIBER ✦

Pharmacokinetics and pharmacological effect of lerisetron, a new 5-HT3 antagonist, in rats

✍ Scribed by Nerea Jauregizar; Rosario Calvo; Elena Suarez; Antonio Quintana; Ewa Raczka; John C. Lukas

Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 219 KB
Volume: 91
Category: Article
ISSN: 0022-3549
DOI: 10.1002/jps.1169

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

History and New Developments. Pharmacolo

History and New Developments. Pharmacology of 5-HT3 Antagonists

✍ Andre Rex; Bettina Bert; Heidrun Fink 📂 Article 📅 2007 🏛 John Wiley and Sons ⚖ 11 KB

L-683,877: Pharmacological profile of a

L-683,877: Pharmacological profile of a novel 5-HT3 receptor antagonist

✍ Dr. David Tattersall; Nigel Newberry; Margaret S. Beer; Mike Rigby; Michael Gilb 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 731 KB

Pharmacological properties of dolasetron

Pharmacological properties of dolasetron, a potent and selective antagonist at 5-HT3 receptors

✍ Robert C. Miller; Martin Galvan; Maurice W. Gittos; Paul L. M. van Giersbergen; 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 626 KB

In vivo pharmacology of irindalone, a 5-

In vivo pharmacology of irindalone, a 5-HT2 receptor antagonist with predominant peripheral effects

✍ Jørn Arnt; Klaus P. Bøgesø; Vita Boeck; Anne V. Christensen; Nils Dragsted; John 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 756 KB

Zatosetron, a selective 5-HT3 receptor a

Zatosetron, a selective 5-HT3 receptor antagonist: Pharmacological activities of human and animal metabolites

✍ Marlene L. Cohen; William Bloomquist; Christopher R. Schmid; David W. Robertson; 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 555 KB

## Abstract Zatosetron is a potent, orally active 5‐HT~3~ receptor antagonist with a long duration of activity in laboratory animals and humans. Several metabolites have been detected in plasma and urine of humans and experimental animals receiving zatosetron. The present study was designed to expl

Nonlinear pharmacokinetics of TAK-044, a

Nonlinear pharmacokinetics of TAK-044, a new endothelin antagonist, in rats

✍ Toshiyuki Takeuchi; Yoshihiko Tagawa; Kiyoshi Hagihara; Yoshihiro Maeshiba; Kenj 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB